Literature DB >> 33074877

Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".

Richard D Schulick1,2,3, Atsushi Oba4,5,6, Marco Del Chiaro1,2,3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33074877     DOI: 10.1097/SLA.0000000000004275

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  2 in total

1.  Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer.

Authors:  Jin He; Richard D Schulick; Marco Del Chiaro
Journal:  Ann Surg Oncol       Date:  2021-01-07       Impact factor: 5.344

2.  Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.

Authors:  Yueming Zhang; Yaolin Xu; Dansong Wang; Tiantao Kuang; Wenchuan Wu; Xuefeng Xu; Dayong Jin; Wenhui Lou
Journal:  Int J Clin Oncol       Date:  2020-09-21       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.